Making acute leukemia clinical trial data accessible, visual, and actionable — for patients, caregivers, advocates, and clinicians.

Understanding the treatment landscape is the first step towards effective advocacy. We built the Drug Development Dashboard to put that understanding within reach of everyone touched by acute leukemia.

Thousands of clinical trials in acute leukemia are registered on ClinicalTrials.gov — a vast, publicly available dataset. The challenge has never been access to the data. It has been making sense of it. Filtering out noise, spotting patterns, drawing comparisons, and turning raw numbers into arguments that move policy forward.

That’s the problem ALAN set out to solve with the Drug Development Dashboard: a free, interactive tool that aggregates all relevant acute leukemia trial data from ClinicalTrials.gov and presents it through purpose-built visualisations designed for advocacy, clinical practice, and patient engagement.

What you’ll find inside

The dashboard gives you a comprehensive, filterable view of the clinical research landscape across AML, ALL, and APL. Every chart and data point is sourced directly from ClinicalTrials.gov, refreshed once a month so you’re always working with current information.

Dashboard filters

Use any combination of the following to zero in on exactly the data you need:

• Study timeline Filter by trial start and completion dates

• Geographic focus Narrow results by country

• Patient population Filter by age of enrolled participants

• Condition Focus on AML, ALL, or APL specifically

• Study status View only active, recruiting, or not-yet-recruiting studies

• Research phase Filter by Phase I, II, III, or IV

Who is it for?

We built the dashboard with a broad audience in mind. Whether you’re approaching the data from a personal, professional, or policy perspective, there’s a way in.

• Patients & Caregivers : Explore what’s being studied for your specific diagnosis, and find trial matching support through ancora.ai

• Advocates & Campaigners: Download graphs and data to support policy conversations, funding arguments, and awareness campaigns

• Clinicians & Researchers: Stay informed about the evolving research landscape and track changes across trial phases and conditions

Turning data into advocacy

ClinicalTrials.gov is an extraordinary resource, but it wasn’t built for advocates. Navigating its raw search interface to produce campaign-ready evidence is time-consuming and requires a level of data literacy most people shouldn’t need to develop just to make their case.

The ALAN dashboard does that work for you. The visualisations are designed specifically to surface insights that matter for advocacy — trial gaps by condition, phase distribution, geographic concentration of research, and more.

Once you’ve found the graphs that tell your story, download them as PNG images or a full PDF report for use in presentations, funding applications, or policy submissions.— ALAN Drug Development Dashboard guidance

If you use data from the dashboard in your work, please credit it as: Acute Leukemia Advocates Network.

Keeping up with what’s new

The dashboard includes a dedicated Updates tab so you can see exactly what has changed since the last monthly data refresh — new studies added, status changes, and notable shifts in the research landscape. It’s a fast way to stay current without having to re-examine the full dataset each time.

Data sourcing note: All information displayed on the Drug Development Dashboard is sourced directly from ClinicalTrials.gov and refreshed monthly. While ALAN works to ensure accuracy, it cannot be held responsible for errors or omissions in the source data. For questions or feedback, reach out to info@acuteleuk.org.